Med Lett Drugs Ther. 2006 Sep 11;48(1243):73-4.
A live attenuated varicella-zoster vaccine (Zostavax--Merck) has been approved by the FDA for prevention of herpes zoster (HZ; zoster; shingles) in persons > or = 60 years old. Each dose of Zostavax contains about 14 times as much varicella-zoster virus (VZV) as Varivax, which has been used in the US since 1995 to vaccinate against varicella (chicken pox).
一种减毒活水痘带状疱疹疫苗（Zostavax - 默克公司生产）已获美国食品药品监督管理局（FDA）批准，用于预防60岁及以上人群的带状疱疹（HZ；zoster；shingles）。每剂Zostavax所含的水痘带状疱疹病毒（VZV）量约为Varivax的14倍，Varivax自1995年起在美国用于预防水痘（带状疱疹）。
